{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:54:37Z","timestamp":1790423677829,"version":"4.1.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,7,28]],"date-time":"2019-07-28T00:00:00Z","timestamp":1564272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Investissements d\u2019avenir","award":["ANR-10-IAIHU-06"],"award-info":[{"award-number":["ANR-10-IAIHU-06"]}]},{"name":"Sant\u00e9 Publique France"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The French epidemics of iatrogenic Creutzfeldt-Jakob disease after growth hormone (GH) treatment provide an opportunity to understand factors governing the inter-human transmission of prions. The present analysis relying on truncated Weibull distribution supports a relationship between host genetics, dose of the at-risk GH, age at treatment onset, and duration of the incubation period.<\/jats:p>","DOI":"10.1093\/cid\/ciz692","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T11:25:44Z","timestamp":1563967544000},"page":"1487-1490","source":"Crossref","is-referenced-by-count":7,"title":["Factors Influencing the Incubation of an Infectious Form of Creutzfeldt-Jakob Disease"],"prefix":"10.1093","volume":"70","author":[{"given":"Laur\u00e8ne","family":"Peckeu","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM , CNRS UMR 7225, Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Brandel","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM , CNRS UMR 7225, Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM"},{"name":"AP-HP, Cellule Nationale de R\u00e9f\u00e9rence des maladies de Creutzfeldt-Jakob, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlette","family":"Welaratne","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM , CNRS UMR 7225, Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM"},{"name":"AP-HP, Cellule Nationale de R\u00e9f\u00e9rence des maladies de Creutzfeldt-Jakob, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Amar","sequence":"additional","affiliation":[{"name":"AP-HP, H\u00f4pital Lariboisi\u00e8re, Service de Biochimie et Biologie Mol\u00e9culaire, Universit\u00e9 Paris Descartes , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Costagliola","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Ha\u00efk","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM , CNRS UMR 7225, Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM"},{"name":"AP-HP, Cellule Nationale de R\u00e9f\u00e9rence des maladies de Creutzfeldt-Jakob, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re"},{"name":"AP-HP, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re, Laboratoire de Neuropathologie R Escourolle"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,7,28]]},"reference":[{"key":"2024111411412127600_CIT0001","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1212\/01.WNL.0000084000.27403.15","article-title":"Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone","volume":"61","author":"Swerdlow","year":"2003","journal-title":"Neurology"},{"key":"2024111411412127600_CIT0002","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jama.1991.03460070062043","article-title":"Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States","volume":"265","author":"Fradkin","year":"1991","journal-title":"JAMA"},{"key":"2024111411412127600_CIT0003","doi-asserted-by":"crossref","first-page":"e724","DOI":"10.1212\/WNL.0000000000006028","article-title":"Susceptibility to Creutzfeldt-Jakob disease after human growth hormone treatment in France","volume":"91","author":"Peckeu","year":"2018","journal-title":"Neurology"},{"key":"2024111411412127600_CIT0004","doi-asserted-by":"crossref","first-page":"13239","DOI":"10.1073\/pnas.95.22.13239","article-title":"Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease","volume":"95","author":"Cerven\u00e1kov\u00e1","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024111411412127600_CIT0005","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJMc1610003","article-title":"Variant Creutzfeldt-Jakob disease in a patient with heterozygosity at PRNP Codon 129","volume":"376","author":"Mok","year":"2017","journal-title":"N Engl J Med"},{"key":"2024111411412127600_CIT0006","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/WNL.53.6.1197","article-title":"Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France","volume":"53","author":"Huillard d\u2019Aignaux","year":"1999","journal-title":"Neurology"},{"key":"2024111411412127600_CIT0007","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/sim.4780070305","article-title":"A model-based approach to characterize the incubation period of paediatric transfusion-associated acquired immunodeficiency syndrome","volume":"7","author":"Lui","year":"1988","journal-title":"Stat Med"},{"key":"2024111411412127600_CIT0008","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1073\/pnas.121172098","article-title":"Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice","volume":"98","author":"Manolakou","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024111411412127600_CIT0009","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0140-6736(03)13867-6","article-title":"Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK","volume":"362","author":"Brandel","year":"2003","journal-title":"Lancet"},{"key":"2024111411412127600_CIT0010","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/S0140-6736(06)68930-7","article-title":"Kuru in the 21st century\u2014an acquired human prion disease with very long incubation periods","volume":"367","author":"Collinge","year":"2006","journal-title":"Lancet"},{"key":"2024111411412127600_CIT0011","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/256732a0","article-title":"Scrapie incubation time can exceed natural lifespan","volume":"256","author":"Dickinson","year":"1975","journal-title":"Nature"},{"key":"2024111411412127600_CIT0012","doi-asserted-by":"crossref","first-page":"11573","DOI":"10.1038\/srep11573","article-title":"Transmission of scrapie prions to primate after an extended silent incubation period","volume":"5","author":"Comoy","year":"2015","journal-title":"Sci Rep"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz692\/30011867\/ciz692.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/70\/7\/1487\/32921286\/ciz692.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/70\/7\/1487\/32921286\/ciz692.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T12:31:57Z","timestamp":1731587517000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/70\/7\/1487\/5540004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,28]]},"references-count":12,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,28]]},"published-print":{"date-parts":[[2020,3,17]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz692","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4,1]]},"published":{"date-parts":[[2019,7,28]]}}}